Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

ALL Assembly 2018

5 - 6 Oct 2018
Park Inn by Radisson Amsterdam City West HotelPark Inn by Radisson Amsterdam City West Hotel, Amsterdam, Netherlands
Immunological monitoring of patients receiving immunotherapy
Prof Jaques van Dongen - Leiden University, Netherlands
Immunological monitoring of patients receiving immunotherapy ( Prof Jaques van Dongen - Leiden University, Netherlands )
18 Oct 2018
Novel therapies for paediatric B-ALL
Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy
Novel therapies for paediatric B-ALL ( Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy )
18 Oct 2018
Can we reduce the intensity of frontline therapy?
Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy
Can we reduce the intensity of frontline therapy? ( Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy )
18 Oct 2018
Latest concepts in the diagnosis of genetic ALL subtypes
Dr Charles Mullighan - St Jude Children's Research Hospital, Memphis, USA
Latest concepts in the diagnosis of genetic ALL subtypes ( Dr Charles Mullighan - St Jude Children's Research Hospital, Memphis, USA )
18 Oct 2018
In vitro diagnostic models for ALL: what can we learn on actionable targets?
Dr Beat Bornhauser - Senior Scientist, University of Zurich, Zurich, Switzerland
In vitro diagnostic models for ALL: what can we learn on actionable targets? ( Dr Beat Bornhauser - Senior Scientist, University of Zurich, Zurich, Switzerland )
18 Oct 2018
For HSCT in Ph-positive ALL
Prof Oliver Ottmann - Cardiff University, Cardiff, UK
For HSCT in Ph-positive ALL ( Prof Oliver Ottmann - Cardiff University, Cardiff, UK )
18 Oct 2018
Bispecific T-cell engaging therapy for adult ALL
Prof Max Topp - University of Würzburg, Würzburg, Germany
Bispecific T-cell engaging therapy for adult ALL ( Prof Max Topp -  University of Würzburg, Würzburg, Germany )
18 Oct 2018
Optimal use of TKIs for therapy of Ph-positive ALL
Dr Josep Ribera - Catalan Institute of Oncology, Badalona, Spain
Optimal use of TKIs for therapy of Ph-positive ALL ( Dr Josep Ribera - Catalan Institute of Oncology, Badalona, Spain )
18 Oct 2018
Management of relapsed T-ALL in children
Prof Josef Vormoor - Newcastle University, Newcastle, UK
Management of relapsed T-ALL in children ( Prof Josef Vormoor - Newcastle University, Newcastle, UK )
18 Oct 2018
Combining MRD quantitation and genetics in post-remission risk stratification
Dr John Moppett - University Hospitals Bristol NHS Foundation Trust, Bristol, UK
Combining MRD quantitation and genetics in post-remission risk stratification ( Dr John Moppett - University Hospitals Bristol NHS Foundation Trust, Bristol, UK )
18 Oct 2018
Transplanting adult ALL patients
Prof Sebastien Giebel - The Maria Skłodowska-Curie Institute of Oncology, Warsaw...
Transplanting adult ALL patients ( Prof Sebastien Giebel - The Maria Skłodowska-Curie Institute of Oncology, Warsaw, Poland )
18 Oct 2018
Management of MLL-rearranged ALL
Prof Rob Pieters - Princess Maxima Centre for paediatric oncology (UU), Utrecht,...
Management of MLL-rearranged ALL ( Prof Rob Pieters - Princess Maxima Centre for paediatric oncology (UU), Utrecht, Netherlands )
18 Oct 2018
Against HSCT in Ph-positive ALL
Prof Robin Foa - Professor of Haematology and Head of Haematology, University of...
Against HSCT in Ph-positive ALL ( Prof Robin Foa - Professor of Haematology and Head of Haematology, University of Rome, Rome, Italy )
18 Oct 2018
CAR-T cells: challenges and opportunities
Dr Sara Ghorashian - University College London, London, UK
CAR-T cells: challenges and opportunities ( Dr Sara Ghorashian - University College London, London, UK )
18 Oct 2018
Update on targeted therapies for Philadelphia-like ALL
Prof Stephen Hunger - Children’s Hospital of Philadelphia, Philadelphia, USA
Update on targeted therapies for Philadelphia-like ALL ( Prof Stephen Hunger - Children’s Hospital of Philadelphia, Philadelphia, USA )
18 Oct 2018